|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.58 CNY | -1.22% |
|
-3.17% | -19.36% |
| 05-25 | Mayinglong Pharmaceutical Gets Regulatory Approval for Eye Drops | MT |
| 04-24 | Mayinglong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 24.32 | 26.22 | 26.03 |
| Spread/Res. | -7.15% | -13.88% | -13.25% |
| Spread/Supp. | +1.44% | +7.47% | +1.71% |
| Support | 22.26 | 21.01 | 22.2 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 600993 Stock
- Charts Mayinglong Pharmaceutical Group Co., LTD.
Select your edition
All financial news and data tailored to specific country editions
